Back to today’s briefing

Story perspectives

Canada's Drug Reforms Falter Amid Rising Overdose Deaths

2/21/2025

24 4

Summary

Story summary

Canada's drug reform efforts are struggling, especially in British Columbia, where the 2023 decriminalization of small quantities of drugs was met with a tragic rise in overdose deaths, prompting a retreat on reforms. In Ontario, the potential closure of supervised drug-use sites raises alarms about more lives at risk. Meanwhile, the U.S. sees a slight drop in overdose fatalities, but the fentanyl crisis looms large.

1 of 1

Story summary

Canada's drug reform efforts are struggling, especially in British Columbia, where the 2023 decriminalization of small quantities of drugs was met with a tragic rise in overdose deaths, prompting a retreat on reforms. In Ontario, the potential closure of supervised drug-use sites raises alarms about more lives at risk. Meanwhile, the U.S. sees a slight drop in overdose fatalities, but the fentanyl crisis looms large.